SWARTZ ERIC S 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Feb 18, 2010
Insider Transaction Report
Form 4
SWARTZ ERIC S
Director
Transactions
- Purchase
Common Stock, $.001 par value
2010-02-17$3.26/sh+9,000$29,340→ 92,500 total(indirect: By LLC) - Purchase
Common Stock, $.001 par value
2010-02-17$3.27/sh+3,200$10,464→ 95,700 total(indirect: By LLC) - Purchase
Common Stock, $.001 par value
2010-02-17$3.24/sh+2,000$6,480→ 80,000 total(indirect: By LLC) - Purchase
Common Stock, $.001 par value
2010-02-17$3.25/sh+3,500$11,375→ 83,500 total(indirect: By LLC)
Holdings
- 438,379
Common Stock, $.001 par value
- 107,739(indirect: By Swartz Ventures, Inc.)
Common Stock, $.001 par value
- 440,000
Non-Qualified Stock Option (right to buy)
→ Common Stock (440,000 underlying)
Footnotes (2)
- [F1]Includes 52,978 shares held in an Individual Retirement Account (IRA) for the benefit of Eric S. Swartz.
- [F2]N/A